PCM
TMO icon

Pennsylvania Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Pennsylvania Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Sell
557
-149
-21% -$71.5K 0.07% 101
2026
Q1 		$347K Sell
706
-53
-7% -$28.8K 0.1% 83
2025
Q4 		$440K Buy
759
+28
+4% +$15.8K 0.12% 76
2025
Q3 		$355K Sell
731
-29
-4% -$13.5K 0.1% 87
2025
Q2 		$308K Sell
760
-80
-10% -$33.4K 0.1% 87
2025
Q1 		$418K Sell
840
-51
-6% -$27.6K 0.15% 69
2024
Q4 		$464K Sell
891
-3
-0.3% -$1.65K 0.16% 68
2024
Q3 		$553K Sell
894
-589
-40% -$349K 0.2% 60
2024
Q2 		$820K Sell
1,483
-7
-0.5% -$4.01K 0.32% 37
2024
Q1 		$866K Sell
1,490
-57
-4% -$32K 0.36% 39
2023
Q4 		$821K Sell
1,547
-91
-6% -$44K 0.33% 42
2023
Q3 		$829K Buy
1,638
+56
+4% +$29.8K 0.34% 39
2023
Q2 		$825K Buy
1,582
+10
+0.6% +$5.4K 0.35% 39
2023
Q1 		$906K Sell
1,572
-62
-4% -$34.9K 0.44% 37
2022
Q4 		$952K Sell
1,634
-93
-5% -$49.3K 0.5% 36
2022
Q3 		$876K Sell
1,727
-12
-0.7% -$6.72K 0.48% 28
2022
Q2 		$945K Sell
1,739
-20
-1% -$11K 0.5% 29
2022
Q1 		$1.04M Sell
1,759
-619
-26% -$356K 0.44% 29
2021
Q4 		$1.59M Sell
2,378
-13
-0.5% -$8.12K 0.54% 26
2021
Q3 		$1.46M Hold
2,391
– – 0.65% 22
2021
Q2 		$1.24M Sell
2,391
-31
-1% -$14.6K 0.61% 23
2021
Q1 		$1.1M Buy
2,422
+417
+21% +$199K 0.65% 24
2020
Q4 		$1.01M Buy
2,005
+333
+20% +$156K 0.66% 24
2020
Q3 		$754K Buy
+1,672
New +$691K 0.59% 28
2020
Q2 		– Sell
-1,772
Closed -$500K – 137
2020
Q1 		$500K Sell
1,772
-20
-1% -$6.31K 0.64% 25
2019
Q4 		$582K Buy
+1,792
New +$543K 0.55% 32

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Pennsylvania Capital Management's TMO Position: Q2 2026 in Review

Pennsylvania Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 21% in Q2 2026, selling an estimated $71.5K and leaving 557 shares worth $279K. The position accounts for 0.07% of the portfolio, ranked #101.

Pennsylvania Capital Management first reported a position in TMO in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.59M in Q4 2021. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Pennsylvania Capital Management held 557 shares of Thermo Fisher Scientific worth $279K as of Q2 2026.
  • Pennsylvania Capital Management sold 149 Thermo Fisher Scientific shares in Q2 2026, an estimated $71.5K.
  • Thermo Fisher Scientific made up 0.07% of Pennsylvania Capital Management's portfolio in Q2 2026, its #101 holding.
  • Pennsylvania Capital Management first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 26 quarters since.
  • Pennsylvania Capital Management's Thermo Fisher Scientific position peaked at $1.59M in Q4 2021.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Pennsylvania Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.